Congressman Troy Carter (D-LA) has officially joined as a cosponsor of the Marijuana 1-to-3 Act of 2025, becoming the first Democrat to support the proposal and giving it bipartisan backing.

The bill, introduced in August by Representative Gregory Steube (R-FL), would direct the Attorney General to move marijuana from Schedule I to Schedule III of the federal Controlled Substances Act within 60 days of enactment.

Representative David Joyce (R-OH), a longtime supporter of federal marijuana reform and co-chair of the Congressional Cannabis Caucus, became the first cosponsor in September. With Carter’s endorsement, the legislation now has backing from both sides of the aisle, reflecting growing bipartisan agreement that marijuana’s current Schedule I classification is outdated.

If enacted, the Marijuana 1-to-3 Act would reschedule marijuana alongside substances like ketamine and certain anabolic steroids, a move that would acknowledge its medical value and reduce barriers to scientific research. While the measure would not legalize marijuana outright, shifting to Schedule III would ease tax restrictions on state-licensed marijuana businesses under Section 280E of the Internal Revenue Code, allowing them to deduct standard business expenses.

The proposal has been referred to the House Energy and Commerce Committee, as well as the Judiciary Committee. The proposal’s consideration comes as the Trump Administration is expected to move forward with rescheduling cannabis via administrative action.